此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Nasal High-flow Oxygen Therapy During Rehabilitive Exercise Training in ILD (PID-OX)

2026年6月25日 更新者:Frédéric Hérengt

Does Nasal High-Flow Oxygen Potentiate the Effects of Rehabilitative Exercise Training in Chronic Fibrotic Interstitial Lung Disease?

Although uncommon, interstitial lung diseases (ILDs), and particularly idiopathic pulmonary fibrosis (IPF), are progressive, irreversible, and ultimately fatal without treatment. Pharmacological therapies can slow the decline in forced vital capacity (FVC) and six-minute walk distance (6MWD), but they do not improve exercise-related respiratory limitations or quality of life.

Therefore, pulmonary rehabilitation (PR) is recommended for patients with a confirmed diagnosis of ILD/IPF who experience exercise limitation and significant functional impairment. However, the benefits of PR remain modest, and the optimal rehabilitation strategies for these patients have yet to be defined, particularly given the severe dyspnea and often profound exertional hypoxemia that characterize the disease.

To optimize the effects of PR, especially exercise training, the use of high-flow nasal oxygen (HFNO) during exercise has been proposed in certain respiratory conditions such as chronic obstructive pulmonary disease (COPD). By improving oxygenation and exercise tolerance, HFNO applied during exercise training sessions may enhance the effectiveness of pulmonary rehabilitation.

研究概览

研究类型

介入性

注册 (实际的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Auvergne-Rhône-Alpes
      • Dieulefit、Auvergne-Rhône-Alpes、法国、26220
        • Association Dieulefit Santé

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Age ≥18 years.
  • Confirmed diagnosis of interstitial lung disease (ILD).
  • Indication for pulmonary rehabilitation according to current guidelines, defined as exercise limitation associated with significant functional impairment.
  • Clinically stable disease with no recent exacerbation requiring treatment modification within the previous 3 months.
  • Affiliation with a health insurance/social security system.
  • Ability to understand the study procedures and provide written informed consent.

Non-inclusion Criteria:

  • Inability to perform cycle ergometer exercise testing.
  • Participation in a pulmonary rehabilitation program within the previous 6 months.
  • Any contraindication to exercise testing according to standard clinical practice.
  • Inability to provide informed consent.
  • Current participation in another interventional study during an exclusion period.
  • Pregnant or breastfeeding women.
  • Individuals deprived of liberty by judicial or administrative decision.
  • Adults under legal protection or guardianship.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Nasal high-flow oxygen therapy
Nasal high-flow oxygen therapy (flow= 30-70 L/min; inspired fraction of O2= 0.50)
Participants will undergo a standardized 4-week pulmonary rehabilitation program consisting of respiratory therapy exercises (20min), cycle ergometer endurance training, outdoor walking, calisthenics, and muscle strengthening exercises, performed 5 days per week for a total of 20 sessions. During cycle ergometer endurance training, participants will receive NHFO2.
有源比较器:Conventional oxygen therapy
Conventional oxygen therapy (nasal canula; flow= 4-9 L/min; inspired fraction of O2= 1.0)
Participants will undergo a standardized 4-week pulmonary rehabilitation program consisting of respiratory therapy exercises (20min), cycle ergometer endurance training, outdoor walking, calisthenics, and muscle strengthening exercises, performed 5 days per week for a total of 20 sessions. During cycle ergometer endurance training, participants will receive conventional O2 therapy.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Constant Work Rate Endurance Time (CWRET)
大体时间:Baseline and end of the 4-week PR program.
Endurance time measured during a constant-load exercise test performed at 70% of peak work rate (PWR) in room air determined during baseline incremental cardiopulmonary exercise testing.
Baseline and end of the 4-week PR program.

次要结果测量

结果测量
措施说明
大体时间
Six-Minute Walk Distance
大体时间:Baseline and end of the 4-week pulmonary rehabilitation.
Distance walked during the 6-Minute Walk Test.
Baseline and end of the 4-week pulmonary rehabilitation.
Dyspnea, Leg Discomfort and Rate of Percieved Exertion (RPE)
大体时间:Dyspnea and Leg Discomfort : during constant-load exercise test and 6-min walk test, at baseline and end of 4-week PR. Dyspnea and RPE : during each of the 20 exercise training sessions on a bicycle ergometer.
Using the modified CR10 Borg scale (ranging from 0 [nothing at all] to 10 [maximal]) for dyspnea and leg discomfort; using the 6 (no exertion at all) - 20 (maximum exertion) Borg scale for RPE.
Dyspnea and Leg Discomfort : during constant-load exercise test and 6-min walk test, at baseline and end of 4-week PR. Dyspnea and RPE : during each of the 20 exercise training sessions on a bicycle ergometer.
Pulmonary responses to exercise
大体时间:Baseline and end of the 4-week pulmonary rehabilitation.
Pulmonary exercise parameters, including ventilation (VE, L/min), gas exchange (VO2, VCO2, L/min), assessed during a cardiopulmonary exercise test (CPET) and during constant-load cycle ergometer endurance tests.
Baseline and end of the 4-week pulmonary rehabilitation.
Oxygen saturation
大体时间:During each of the 20 exercise training sessions on a bicycle ergometer.
By pulse oximetry
During each of the 20 exercise training sessions on a bicycle ergometer.
Heart Rate
大体时间:Continuous monitoring throughout the cardiopulmonary test and during each of the 20 exercise training sessions on a bicycle ergometer.
Using electrocardiogram, in beats/min
Continuous monitoring throughout the cardiopulmonary test and during each of the 20 exercise training sessions on a bicycle ergometer.
Power
大体时间:During each of the 20 exercise training sessions on a bicycle ergometer. During the CPET, baseline and end of the 4-week pulmonary rehabilitation
During each of the 20 exercise training sessions on a bicycle ergometer. During the CPET, baseline and end of the 4-week pulmonary rehabilitation
Near Infrared Spetroscopy
大体时间:Baseline and end of the 4-week PR
Of the Vastus Lateralis, used during the CPET and CWRET.
Baseline and end of the 4-week PR
King's Brief Interstitial Lung Disease (K-BILD)
大体时间:Baseline and end of the 4-week pulmonary rehabilitation
Ranging from 0 (worst) to 100 (better)
Baseline and end of the 4-week pulmonary rehabilitation
modified Medical Research Council (mMRC)
大体时间:Baseline and end of the 4-week pulmonary rehabilitation
Ranging from 0 (better) to 4 (worst)
Baseline and end of the 4-week pulmonary rehabilitation
Hospital Anxiety and Depression Scale (HADS)
大体时间:Baseline and end of the 4-week pulmonary rehabilitation
Ranging from 0 (better) to 21 (worst)
Baseline and end of the 4-week pulmonary rehabilitation
Pichot Fatigue Scale
大体时间:Baseline and end of the 4-week pulmonary rehabilitation
Ranging from 0 (better) to 32 (worst)
Baseline and end of the 4-week pulmonary rehabilitation

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2022年8月1日

初级完成 (实际的)

2025年5月31日

研究完成 (实际的)

2025年5月31日

研究注册日期

首次提交

2026年6月17日

首先提交符合 QC 标准的

2026年6月25日

首次发布 (实际的)

2026年7月1日

研究记录更新

最后更新发布 (实际的)

2026年7月1日

上次提交的符合 QC 标准的更新

2026年6月25日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

其他研究编号

  • Dieulefit Sante

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

Data will be shared upon reasonable request to the contact person or contact back up person.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅